Arkolith/Insider Trading/AKBA/Form 4

Malabre Richard C

SVP, Chief Accounting OfficerAkebia Therapeutics, Inc. (AKBA) · full profile →Form 4 · filed Jun 11, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$60K
Net Open-Market Flow
-$60K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 9, 2025Sell(S)15K$4.01$60K267K
Jun 9, 2025Option exercise(M)15K$1.68$25K282K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 9, 2025Option exercise(M)15K—$0321K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-25-004717) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML